HCT 投稿者：Lazaro 投稿日：2026/01/31(Sat) 22:35 No.31116119 
Rituximab is a chimeric murine/human monoclonal immunoglobulin G1 antibody that targets CD20, which is a B-cell differentiation marker.6 CD20 is a cell-floor marker particularly discovered on pre-B and mature B lymphocytes and isn't discovered on different cell varieties or free in circulation.7 The one binding site for rituximab is CD20 on B-cells. Schematic illustration of the mechanism of motion of rituximab. The antibody labels B lymphocytes, which have the CD20 cell marker. These cells are then killed by 1 of three mechanisms: antibody-dependent cytotoxicity, complement-dependent cytotoxicity, or stimulation of apoptosis. Illustration by Priya A. Rajdev. Rituximab has been accepted by the FDA for varied B-cell non-Hodgkin lymphomas (clinical case: Figs 2 and 3) and rheumatoid arthritis. There are a number of off-label makes use of, together with chronic lymphocytic leukemia, systemic lupus erythematosus, a number of sclerosis, autoimmune hemolytic anemia, posttransplant lymphoproliferative disorder, graft-versus-host illness, pemphigus vulgaris, chronic immune-mediated thrombocytopenia, and Evans Syndrome. A 68-12 months-outdated girl introduced with clumsiness, dropping issues from her proper hand, issue talking, and proper facial droop.
Here is my webpage :: How much is the 100mg/ml and 500mg/ml Rituximab (MabThera)? (HCT (https://www.facebook.com/rituximabprecio/))
|